Observing frailty in lung cancer patients
Observation of Frailty in Lung Cancer Patients and Its Influencing Factors
This study looks at how different physical, mental, and social factors affect frailty in lung cancer patients to help find better ways to support them in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Peking University Third Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06448455 on ClinicalTrials.gov |
What this trial studies
This study evaluates the frailty status of lung cancer patients using the Integrated Conceptual Model of Frailty and the Frailty Framework among Vulnerable Population. It aims to comprehensively analyze the physiological, psychological, and social factors contributing to frailty in this population. By identifying the influencing factors related to frailty, the study seeks to lay the groundwork for future intervention research targeting lung cancer patients. The findings will help understand the complex interplay of various factors that lead to frailty in these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are lung cancer patients aged 18 and older who can complete questionnaires independently or with guidance.
Not a fit: Patients with serious physical diseases, cognitive impairments, or those participating in other studies may not benefit from this research.
Why it matters
Potential benefit: If successful, this study could lead to improved interventions for lung cancer patients, enhancing their overall health outcomes.
How similar studies have performed: While there is limited research on frailty in lung cancer patients, previous studies have identified various influencing factors, indicating a need for further exploration in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Lung cancer was diagnosed by pathology or cytology; * Age ≥ 18 years; * Be able to complete this questionnaire independently or under the guidance of the researcher; * Informed consent and voluntary participation in this study. Exclusion Criteria: * Serious physical diseases (heart, lung, kidney and other important organ failure); * Patients with a history of dementia, mental illness, intellectual disability, and cognitive impairment; * Blind, deaf and aphasic patients; * Participate in other studies.
Where this trial is running
Beijing, Beijing Municipality
- Peking University Third Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Principal investigator: Jing Wang — Peking University Third Hospital Library
- Study coordinator: Jing Wang
- Email: nmwj0723@163.com
- Phone: 13699176380
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.